UROGEN PHARMA - INCREASES 2026 OPERATING EXPENSES GUIDANCE TO $260 MLN-$270 MLN INCLUDING $20 MLN-$24 MLN SHARE-BASED COMP

Reuters · 3d ago

Please log in to view news